These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1486045)

  • 41. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
    Hovdenes J; Solheim BG
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force.
    Treleaven J; Gennery A; Marsh J; Norfolk D; Page L; Parker A; Saran F; Thurston J; Webb D
    Br J Haematol; 2011 Jan; 152(1):35-51. PubMed ID: 21083660
    [No Abstract]   [Full Text] [Related]  

  • 43. [A case of fatal graft-versus-host disease following blood transfusion in esophageal cancer documented by homozygous changes of HLA typing].
    Soeda K; Onoda S; Kozu T; Okuyama K; Koide Y; Isono K
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1040-3. PubMed ID: 2233658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfusion-associated graft-versus-host disease: scratching the surface.
    Shivdasani RA; Anderson KC
    Transfusion; 1993 Sep; 33(9):696-7. PubMed ID: 8212111
    [No Abstract]   [Full Text] [Related]  

  • 45. Bone marrow transplantation and graft-versus-host disease.
    Powles RL
    Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
    [No Abstract]   [Full Text] [Related]  

  • 46. An immunohistological study of post-transfusion graft-versus-host disease (GVHD).
    Hojo H; Kainuma Y; Kunori T; Wachi E; Wakasa H
    Fukushima J Med Sci; 1993 Dec; 39(2):77-87. PubMed ID: 7927138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. When to administer modified blood products.
    Fitzpatrick L
    Nursing; 2002 May; 32(5):36-41; quiz 42. PubMed ID: 12035651
    [No Abstract]   [Full Text] [Related]  

  • 48. Mixed epidermal cell-lymphocyte reaction in prediction of acute graft-versus-host disease in bone marrow recipients.
    Bagot M; Cordonnier C; Vernant JP; Dubertret L; Rochant H; Levy JP
    J Natl Cancer Inst; 1986 Jun; 76(6):1317-9. PubMed ID: 3520075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute and chronic graft-versus-host disease in man.
    Sullivan KM
    Int J Cell Cloning; 1986; 4 Suppl 1():42-93. PubMed ID: 2943828
    [No Abstract]   [Full Text] [Related]  

  • 50. [Graft vs host reaction and graft vs host diseases].
    Sakagami K; Orita K
    Nihon Rinsho; 1985 Jan; 43(1):97-103. PubMed ID: 3886972
    [No Abstract]   [Full Text] [Related]  

  • 51. Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery.
    Rososhansky S; Badonnel MC; Hiestand LL; Popovsky MA; Szymanski IO
    Vox Sang; 1999; 76(1):59-63. PubMed ID: 9933856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.
    van der Mast BJ; Hornstra N; Ruigrok MB; Claas FH; van Rood JJ; Lagaaij EL
    Lancet; 1994 Mar; 343(8900):753-7. PubMed ID: 7907730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 54. [Bullous skin rash in a 61-year-old man].
    Phelippeau M; Bonnet D; Laurenty AP; Meyer N; Apoil PA; Selves J; Alric L; Saadoun D
    Rev Med Interne; 2011 Feb; 32(2):120-3. PubMed ID: 21239087
    [No Abstract]   [Full Text] [Related]  

  • 55. [Characteristic of adverse reactions after blood components transfusion].
    Król D; Mazur B; Drybańska B
    Przegl Lek; 2009; 66(8):453-8. PubMed ID: 20043593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
    Takahashi K
    Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukocyte-reduced blood components in transfusion medicine. Current indications and prospects for the future.
    Klapper EB; Goldfinger D
    Clin Lab Med; 1992 Dec; 12(4):711-21. PubMed ID: 1286560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perspectives on transfusion-associated graft-versus-host disease.
    Jeter E
    Int J Artif Organs; 1994 Jan; 17(1):1-4. PubMed ID: 8188393
    [No Abstract]   [Full Text] [Related]  

  • 60. Incidence of anti-host cytotoxic and proliferative T cell responses after HLA-identical bone marrow transplantation (BMT).
    van Els C; Bakker A; Zwaan F; van Rood JJ; Goulmy E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2987-8. PubMed ID: 2468249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.